SG Americas Securities
HAE icon

SG Americas Securities’s Haemonetics HAE Stock Holding History

SG Americas Securities’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$256K Sell
4,540
-9,679
-68% -$630K ﹤0.01% 2528
2025
Q4 		$1.14M Buy
14,219
+1,311
+10% +$88.1K ﹤0.01% 1906
2025
Q3 		$629K Buy
12,908
+1,114
+9% +$69K ﹤0.01% 1920
2025
Q2 		$880K Buy
11,794
+1,214
+11% +$80.4K ﹤0.01% 1261
2025
Q1 		$672K Buy
10,580
+8,848
+511% +$602K ﹤0.01% 1530
2024
Q4 		$135K Sell
1,732
-8,100
-82% -$651K ﹤0.01% 2495
2024
Q3 		$790K Sell
9,832
-9,414
-49% -$761K ﹤0.01% 1279
2024
Q2 		$1.59M Buy
19,246
+17,161
+823% +$1.51M 0.01% 1074
2024
Q1 		$178K Sell
2,085
-1,945
-48% -$153K ﹤0.01% 2059
2023
Q4 		$345K Buy
+4,030
New +$348K ﹤0.01% 1711
2023
Q2 		– Sell
-22,290
Closed -$1.84M – 2637
2023
Q1 		$1.84M Buy
22,290
+13,622
+157% +$1.1M 0.02% 713
2022
Q4 		$682K Buy
8,668
+2,777
+47% +$223K 0.01% 1268
2022
Q3 		$436K Sell
5,891
-2,257
-28% -$162K 0.01% 1670
2022
Q2 		$531K Sell
8,148
-3,063
-27% -$181K 0.01% 1908
2022
Q1 		$709K Sell
11,211
-5,857
-34% -$318K 0.01% 1659
2021
Q4 		$905K Sell
17,068
-3,670
-18% -$224K ﹤0.01% 1722
2021
Q3 		$1.46M Buy
20,738
+16,298
+367% +$1.03M 0.01% 1561
2021
Q2 		$296K Sell
4,440
-4,430
-50% -$313K ﹤0.01% 2173
2021
Q1 		$985K Sell
8,870
-37,315
-81% -$4.62M 0.01% 1553
2020
Q4 		$5.48M Buy
46,185
+39,448
+586% +$4.25M 0.03% 454
2020
Q3 		$588K Buy
6,737
+1,950
+41% +$170K ﹤0.01% 1529
2020
Q2 		$429K Sell
4,787
-137,756
-97% -$13.9M ﹤0.01% 2223
2020
Q1 		$14.2M Buy
142,543
+133,230
+1,431% +$14.4M 0.13% 133
2019
Q4 		$1.07M Sell
9,313
-1,694
-15% -$205K 0.01% 1220
2019
Q3 		$1.39M Buy
11,007
+5,851
+113% +$743K 0.01% 1201
2019
Q2 		$620K Sell
5,156
-11,450
-69% -$1.13M ﹤0.01% 1752
2019
Q1 		$1.45M Buy
16,606
+5,188
+45% +$472K 0.01% 1055
2018
Q4 		$1.14M Buy
11,418
+8,068
+241% +$848K 0.01% 1234
2018
Q3 		$384K Sell
3,350
-7,421
-69% -$768K ﹤0.01% 2243
2018
Q2 		$966K Sell
10,771
-669
-6% -$56.5K 0.01% 1467
2018
Q1 		$837K Buy
11,440
+5,354
+88% +$367K 0.01% 1481
2017
Q4 		$353K Sell
6,086
-966
-14% -$50.9K ﹤0.01% 2070
2017
Q3 		$316K Buy
+7,052
New +$293K ﹤0.01% 2185
2017
Q2 		– Sell
-11,537
Closed -$468K – 3317
2017
Q1 		$468K Buy
+11,537
New +$451K ﹤0.01% 1895
2016
Q4 		– Sell
-12,899
Closed -$467K – 3262
2016
Q3 		$467K Buy
+12,899
New +$443K ﹤0.01% 1766
2015
Q3 		– Sell
-2,577
Closed -$107K – 2349
2015
Q2 		$107K Buy
+2,577
New +$109K ﹤0.01% 2331
2015
Q1 		– Sell
-14,958
Closed -$560K – 2748
2014
Q4 		$560K Buy
+14,958
New +$548K ﹤0.01% 1571
2014
Q2 		– Sell
-9,150
Closed -$298K – 2592
2014
Q1 		$298K Buy
+9,150
New +$350K ﹤0.01% 1751
2013
Q4 		– Sell
-9,826
Closed -$392K – 2784
2013
Q3 		$392K Buy
+9,826
New +$412K ﹤0.01% 1752

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SG Americas Securities's HAE Position: Q1 2026 in Review

SG Americas Securities reduced its Haemonetics (HAE) stake by 68% in Q1 2026, selling an estimated $630K and leaving 4,540 shares worth $256K. The position accounts for ﹤0.01% of the portfolio, ranked #2528.

SG Americas Securities first reported a position in HAE in Q3 2013 and has held it in 39 quarters since. The position peaked at $14.2M in Q1 2020. 324 funds tracked by Wall St. Rank hold HAE as of Q1 2026.

  • SG Americas Securities held 4,540 shares of Haemonetics worth $256K as of Q1 2026.
  • SG Americas Securities sold 9,679 Haemonetics shares in Q1 2026, an estimated $630K.
  • Haemonetics made up ﹤0.01% of SG Americas Securities's portfolio in Q1 2026, its #2528 holding.
  • SG Americas Securities first reported a position in Haemonetics in Q3 2013 and has held it in 39 quarters since.
  • SG Americas Securities's Haemonetics position peaked at $14.2M in Q1 2020.
  • 324 funds tracked by Wall St. Rank held Haemonetics as of Q1 2026.

Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.